Deutsch E - Search Results

1

[Cell cycle, mitosis and therapeutic applications].

Levy A, Albiges-Sauvin L, Massard C, Soria JC, Deutsch E. Levy A, et al. Among authors: deutsch e. Bull Cancer. 2011 Oct;98(9):1037-45. doi: 10.1684/bdc.2011.1382. Bull Cancer. 2011. PMID: 21669563 Free article. Review. French.

2

Chemoprevention of lung cancer.

Soria JC, Kim ES, Fayette J, Lantuejoul S, Deutsch E, Hong WK. Soria JC, et al. Among authors: deutsch e. Lancet Oncol. 2003 Nov;4(11):659-69. doi: 10.1016/s1470-2045(03)01244-0. Lancet Oncol. 2003. PMID: 14602246 Review.

3

Tyrosine kinase inhibitor AG1024 exerts antileukaemic effects on STI571-resistant Bcr-Abl expressing cells and decreases AKT phosphorylation.

Deutsch E, Maggiorella L, Wen B, Bonnet ML, Khanfir K, Frascogna V, Turhan AG, Bourhis J. Deutsch E, et al. Br J Cancer. 2004 Nov 1;91(9):1735-41. doi: 10.1038/sj.bjc.6602190. Br J Cancer. 2004. PMID: 15494718 Free PMC article.

4

[Perspectives in biological modulation of radiotherapy].

Deutsch E, Huguet F. Deutsch E, et al. Bull Cancer. 2005 Jan;92(1):90-6. Bull Cancer. 2005. PMID: 16123013 Free article. Review. French.

5

Tumour stem cell-targeted treatment: elimination or differentiation.

Massard C, Deutsch E, Soria JC. Massard C, et al. Among authors: deutsch e. Ann Oncol. 2006 Nov;17(11):1620-4. doi: 10.1093/annonc/mdl074. Epub 2006 May 3. Ann Oncol. 2006. PMID: 16600978 Free article. Review.

6

[Epidermal growth factor receptor (EGF) in head-and-neck cancers].

Bourhis J, Tao YG, Zhang P, Deutsch E. Bourhis J, et al. Among authors: deutsch e. Bull Cancer. 2007;94(7 Suppl):F189-91. Bull Cancer. 2007. PMID: 17964995 Review. French.

7

Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave Roussy.

Italiano A, Massard C, Bahleda R, Vataire AL, Deutsch E, Magné N, Pignon JP, Vassal G, Armand JP, Soria JC. Italiano A, et al. Among authors: deutsch e. Ann Oncol. 2008 Apr;19(4):787-92. doi: 10.1093/annonc/mdm548. Epub 2007 Nov 27. Ann Oncol. 2008. PMID: 18042834 Free article. Review.

8

Drug insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy.

Loriot Y, Perlemuter G, Malka D, Penault-Llorca F, Boige V, Deutsch E, Massard C, Armand JP, Soria JC. Loriot Y, et al. Among authors: deutsch e. Nat Clin Pract Oncol. 2008 May;5(5):268-78. doi: 10.1038/ncponc1087. Epub 2008 Mar 18. Nat Clin Pract Oncol. 2008. PMID: 18349858 Review.

9

The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trials.

Magné N, Chargari C, Castadot P, Ghalibafian M, Soria JC, Haie-Meder C, Bourhis J, Deutsch E. Magné N, et al. Among authors: deutsch e. Eur J Cancer. 2008 Oct;44(15):2133-43. doi: 10.1016/j.ejca.2008.06.029. Epub 2008 Aug 7. Eur J Cancer. 2008. PMID: 18692389 Review.

10

MVP and vinorelbine for malignant pleural mesothelioma.

Mordant P, Loriot Y, Soria JC, Deutsch E. Mordant P, et al. Among authors: deutsch e. Lancet. 2008 Aug 23;372(9639):629; author reply 629-30. doi: 10.1016/S0140-6736(08)61273-8. Lancet. 2008. PMID: 18722865 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,210 results

Search Page